Non-Hodgkin lymphoma (differentiating types of NHL): Difference between revisions
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
Line 57: | Line 57: | ||
|- | |- | ||
| | | | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |[[Diffuse large B cell lymphoma]]<ref name=" | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Diffuse large B cell lymphoma]]<ref name="Choi2009">{{cite journal |doi=10.1158/1078-0432.CCR-09-0113 |pmid=19706817 |title=A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy |journal=Clinical Cancer Research |volume=15 |issue=17 |pages=5494–502 |year=2009 |last1=Choi |first1=W. W.L. |last2=Weisenburger |first2=D. D. |last3=Greiner |first3=T. C. |last4=Piris |first4=M. A. |last5=Banham |first5=A. H. |last6=Delabie |first6=J. |last7=Braziel |first7=R. M. |last8=Geng |first8=H. |last9=Iqbal |first9=J. |last10=Lenz |first10=G. |last11=Vose |first11=J. M. |last12=Hans |first12=C. P. |last13=Fu |first13=K. |last14=Smith |first14=L. M. |last15=Li |first15=M. |last16=Liu |first16=Z. |last17=Gascoyne |first17=R. D. |last18=Rosenwald |first18=A. |last19=Ott |first19=G. |last20=Rimsza |first20=L. M. |last21=Campo |first21=E. |last22=Jaffe |first22=E. S. |last23=Jaye |first23=D. L. |last24=Staudt |first24=L. M. |last25=Chan |first25=W. C. }}</ref><ref name="Colomo2003">{{cite journal |doi=10.1182/blood-2002-04-1286 |pmid=12393466 |title=Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma |journal=Blood |volume=101 |issue=1 |pages=78–84 |year=2002 |last1=Colomo |first1=L. |last2=López-Guillermo |first2=A |last3=Perales |first3=M |last4=Rives |first4=S |last5=Martínez |first5=A |last6=Bosch |first6=F |last7=Colomer |first7=D |last8=Falini |first8=B |last9=Montserrat |first9=E |last10=Campo |first10=E }}</ref><ref name="Muris2006">{{cite journal |doi=10.1002/path.1924 |pmid=16400625 |title=Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma |journal=The Journal of Pathology |volume=208 |issue=5 |pages=714–23 |year=2006 |last1=Muris |first1=JJF |last2=Meijer |first2=Cjlm |last3=Vos |first3=W |last4=Van Krieken |first4=Jhjm |last5=Jiwa |first5=NM |last6=Ossenkoppele |first6=GJ |last7=Oudejans |first7=JJ }}</ref> | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
Line 576: | Line 576: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|} | |} | ||
<references /> |
Revision as of 15:47, 18 January 2019
Non-Hodgkin lymphoma Microchapters |
Differentiating Non-Hodgkin's Lymphoma |
---|
Treatment |
Case Studies |
Non-Hodgkin lymphoma (differentiating types of NHL) On the Web |
American Roentgen Ray Society Images of Non-Hodgkin lymphoma (differentiating types of NHL) |
Non-Hodgkin lymphoma (differentiating types of NHL) in the news |
Blogs on Non-Hodgkin lymphoma (differentiating types of NHL) |
Risk calculators and risk factors for Non-Hodgkin lymphoma (differentiating types of NHL) |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Overview
Non-Hodgkin lymphoma (differentiating types of NHL)
Differentiating different types of Non-Hodgkin lymphoma. Gold standard for differentiation different types of Non-Hodgkin lymphoma is Biopsy.
Category | Disease | Etiology | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | ||||||||||||||||
Symptoms | Signs | CBC | Immunochemistry | Histopathology | ||||||||||||
Constitutional symptoms | Rash | Abdominal pain | Diarrhea | Mass | Other | WBC | Hb | Plt | ||||||||
Hodgkin's Lymphoma | ||||||||||||||||
Non-Hodgkin's Lymphoma | ||||||||||||||||
Diffuse large B cell lymphoma[1][2][3] |
|
|
|
↓ | ↓ | Nl to ↓ |
Centroblastic
Immunoblastic
Anaplastic
|
|||||||||
B Cell Lymphoma | Mantle cell lymphoma |
|
|
Abdominal distention |
|
|
|
↓ | Nl to ↓ |
|
|
|||||
B-lymphoblastic leukemia/lymphoma |
|
+ | – | – | – |
|
↓ | ↓ | Nl to ↓ |
| ||||||
Follicular lymphoma |
|
Only in 20% of patients: | + | + | ± |
|
↓ | ↓ | Nl to ↓ |
|
|
Lymph node biopsy |
| |||
Burkitt lymphoma |
|
|
|
|
||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
|||||||||||||||
Marginal zone lymphoma | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type |
|
||||||||||||||
Splenic marginal zone lymphoma |
|
|
||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
+ |
|
|
| |||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
|||||||||||||||
Hairy cell leukemia |
|
|
|
|||||||||||||
Category | Disease | Etiology | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | Mass | Other | WBC | Hb | Plt | Immunochemistry | Histopathology | Gold standard | Associated findings | |
T cell lymphoma | Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||
Adult T cell leukemia/lymphoma |
|
|||||||||||||||
Anaplastic large cell lymphoma |
|
|||||||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma |
|
||||||||||||||
Hepatosplenic gamma-delta T-cell lymphoma |
|
|||||||||||||||
Enteropathy-type intestinal T-cell lymphoma |
|
|||||||||||||||
Extranodal T-cell lymphoma, nasal type |
|
|||||||||||||||
Angioimmunoblastic T-cell lymphoma |
|
|||||||||||||||
Peripheral T-cell lymphoma, unspecified |
|
- ↑ Choi, W. W.L.; Weisenburger, D. D.; Greiner, T. C.; Piris, M. A.; Banham, A. H.; Delabie, J.; Braziel, R. M.; Geng, H.; Iqbal, J.; Lenz, G.; Vose, J. M.; Hans, C. P.; Fu, K.; Smith, L. M.; Li, M.; Liu, Z.; Gascoyne, R. D.; Rosenwald, A.; Ott, G.; Rimsza, L. M.; Campo, E.; Jaffe, E. S.; Jaye, D. L.; Staudt, L. M.; Chan, W. C. (2009). "A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy". Clinical Cancer Research. 15 (17): 5494–502. doi:10.1158/1078-0432.CCR-09-0113. PMID 19706817.
- ↑ Colomo, L.; López-Guillermo, A; Perales, M; Rives, S; Martínez, A; Bosch, F; Colomer, D; Falini, B; Montserrat, E; Campo, E (2002). "Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma". Blood. 101 (1): 78–84. doi:10.1182/blood-2002-04-1286. PMID 12393466.
- ↑ Muris, JJF; Meijer, Cjlm; Vos, W; Van Krieken, Jhjm; Jiwa, NM; Ossenkoppele, GJ; Oudejans, JJ (2006). "Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma". The Journal of Pathology. 208 (5): 714–23. doi:10.1002/path.1924. PMID 16400625.